This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
I n this interview for MIA Radio, Brooke Siem speaks with David Taylor and Mark Horowitz about their publication of the Maudsley Deprescribing Guidelines, which is of particular note since the Maudsley Prescribing Guidelines is a leading text in medicine worldwide. Listen to the audio of the interview here. Who’s Maudsley?
For Part 2, we will be covering reader questions on pharmaceutical marketing and issues with psychiatric treatments including psychiatric drugs and electroconvulsive therapy. Listen to the audio of the interview here. Was it related to medical insurance or government programs? Does pharma take the same approach, do you believe?
With Ignition Schools, we’re formalizing the analysis of the colleges and universities where some of the world’s greatest ideas originate, using metrics such as the number of venture-backed companies founded by students and alumni, the total venture money raised by students and alumni, and government research and development expenditures.
You sent some great questions and on this and our next podcast, we will be talking with Bob about Mad in America, the biopsychosocial model, the history of psychiatry, pharmaceutical marketing, and issues with psychiatric treatments including psychiatric drugs and electroconvulsive therapy. Listen to the audio of the interview here.
It is striking how weighted Ireland’s export figures are to the life sciences, medical and pharmaceutical industries craved by the UK Just how significant is apparent when comparing the UK with Ireland.
She was already involved with Mad in America before founding the affiliate siteshe became a science writer, and later a spotlight interview host, after connecting with MIAs science news editor at a conference while doing her PhD at the University of West Georgia.
Listen to the audio of the interview here. For the pharmaceutical industry, the bigger and wider those diseases, the more people who can be diagnosed, and the bigger your markets are. For the pharmaceutical industry, the bigger and wider those diseases, the more people who can be diagnosed, and the bigger your markets are.
The demise of the CMS deal illustrates how difficult it is to figure out how much government health programs should pay for expensive treatments whose long-term benefits are still unclear. Does your PBM require providers to use NDC coding for Specialty Pharmaceuticals to improve monitoring and tracking of utilization?
His Get Attitude podcast won a Communicator Award for Diversity & Inclusion for his 8:46 Interviews Stories of Black America. As a keynote speaker, she has shared the stage with many influencers, including a recent interview with Venus Williams.
Before we begin, I’d like to take a few moments and explain the context of this interview. First, his journal told of how clinical experiences should govern our understanding of the impact of psychiatric treatments, particularly over longer periods of time. Listen to the audio of the interview here.
In our 2015 book Psychiatry Under the Influence , Lisa Cosgrove and I wrote about the STAR*D scandal in depth, as it served as an example of the institutional corruption in psychiatry due to pharmaceutical interests and psychiatrys own guild interests. This was the governing public narrative when the STAR*D trial was conducted.
That’s been the question posed to me in 2023 by interviewers such as Nick Fortino on “ Psychology Is ” and Mollie Adler on “Back from the Borderline. ” The psychiatric-pharmaceutical-industrial complex is fueled by the profits of Big Pharma, which have made a staggering amount of money from psychiatric drugs.
Searching for ways to increase her online sales, she landed a contract with subscriber-based retailer, Stitch Fix, and used a government pandemic relief loan to fulfill the order. ” Danner-Okotie first saw the potential for scaling her clothing brand when the COVID-19 pandemic shut down the boutiques and fairs that carried her designs.
In this interview, he explores the philosophical foundations of psychology, the psychological costs of neoliberalism, and why developing a critical psychology of education and mental health is more urgent than ever. Listen to the audio of the interview here. Neoliberalism provides an answer: govern through choice. I disagree.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content